Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Sep-24 4:51 PM View:  | Passage Bio, Inc. (PASG) | 19-Sep-24 | Sale | 39,300 | $0.71 | $27,903.00 | (< 1%) 7.83M to 7.79M | |
| 18-Sep-24 6:38 PM View: | Passage Bio, Inc. (PASG) | 18-Sep-24 | Sale | 25,631 | $0.73 | $18,710.60 | (< 1%) 7.86M to 7.83M | |
| 18-Sep-24 6:38 PM View: | Passage Bio, Inc. (PASG) | 17-Sep-24 | Sale | 111,400 | $0.73 | $81,322.00 | (1%) 7.97M to 7.86M | |
| 17-Sep-24 8:13 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Conversion Duplicate | 3,062,220 | -- | -- | 100% 0 to 3.06M | |
| 17-Sep-24 8:13 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Private Purchase | 750,000 | $16.00 | $12,000,000.00 | 24% 3.06M to 3.81M | |
| 18-Sep-24 6:38 PM View: | Passage Bio, Inc. (PASG) | 16-Sep-24 | Sale | 63,100 | $0.74 | $46,694.00 | (< 1%) 8.03M to 7.97M | |
| 28-Aug-24 4:26 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 26-Aug-24 | Private Sale Duplicate | 83,695 | $13.00 | $1,088,040.00 | (< 1%) 8.37M to 8.29M | |
| 23-Aug-24 6:38 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 23-Aug-24 | Sale | 69,500 | $13.03 | $905,585.00 | (< 1%) 8.44M to 8.37M | |
| 23-Aug-24 6:38 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 22-Aug-24 | Sale | 391,482 | $12.94 | $5,065,780.00 | (4%) 8.83M to 8.44M | |
| 23-Aug-24 6:38 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 21-Aug-24 | Private Sale | 407,700 | $13.56 | $5,526,600.00 | (4%) 9.24M to 8.83M | |
| 15-Aug-24 4:51 PM View: | Scpharmaceuticals Inc. (SCPH) | 13-Aug-24 | Market Purchase | 500,000 | $4.00 | $2,000,000.00 | 9% 5.56M to 6.06M | 4% |
| 15-Aug-24 5:01 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Aug-24 | Sale | 250,000 | $44.01 | $11,002,500.00 | (20%) 1.27M to 1.02M | |
| 17-Jul-24 8:48 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 16-Jul-24 | Sale | 5,188 | $10.00 | $51,880.00 | (< 1%) 7.57M to 7.56M | |
| 17-Jul-24 8:48 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 15-Jul-24 | Private Sale | 50,976 | $10.00 | $509,760.00 | (< 1%) 7.62M to 7.57M | |
| 02-Jul-24 4:54 PM View: | Tela Bio, Inc. (TELA) | 02-Jul-24 | Sale | 36,600 | $4.54 | $166,164.00 | (1%) 2.44M to 2.41M | |
| 02-Jul-24 4:54 PM View: | Tela Bio, Inc. (TELA) | 01-Jul-24 | Sale | 13,700 | $4.68 | $64,116.00 | (< 1%) 2.46M to 2.44M | |
| 02-Jul-24 4:54 PM View: | Tela Bio, Inc. (TELA) | 28-Jun-24 | Sale | 378,000 | $4.74 | $1,791,720.00 | (13%) 2.84M to 2.46M | |
| 20-Jun-24 5:19 PM View: | Disc Medicine, Inc. (IRON) | 17-Jun-24 | Purchase Duplicate | 83,334 | $36.00 | $3,000,020.00 | 5% 1.7M to 1.79M | |
| 20-May-24 7:47 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-May-24 | Disposition (change in control) | 2,680,500 | -- | -- | (100%) 2.68M to 0 | |
| 20-May-24 5:00 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-May-24 | Private Sale | 1,033,300 | $22.14 | $22,877,300.00 | (12%) 8.95M to 7.92M | |
| 03-May-24 5:16 PM View: | Neuropace Inc (NPCE) | 03-May-24 | Sale | 4,674 | $14.03 | $65,576.20 | (< 1%) 3.41M to 3.41M | |
| 03-May-24 5:16 PM View: | Neuropace Inc (NPCE) | 02-May-24 | Sale | 8,842 | $14.01 | $123,876.00 | (< 1%) 3.42M to 3.41M | |
| 03-May-24 5:16 PM View: | Neuropace Inc (NPCE) | 01-May-24 | Sale | 15,690 | $14.02 | $219,974.00 | (< 1%) 3.44M to 3.42M | |
| 26-Apr-24 5:01 PM View: | Neuropace Inc (NPCE) | 24-Apr-24 | Sale | 1,781 | $14.06 | $25,040.90 | (< 1%) 3.44M to 3.44M | |
| 23-Apr-24 6:38 PM View: | Neuropace Inc (NPCE) | 23-Apr-24 | Sale | 21,791 | $14.29 | $311,393.00 | (< 1%) 3.46M to 3.44M | |
| 23-Apr-24 6:38 PM View: | Neuropace Inc (NPCE) | 22-Apr-24 | Sale | 24,609 | $14.05 | $345,756.00 | (< 1%) 3.48M to 3.46M | |
| 23-Apr-24 6:38 PM View: | Neuropace Inc (NPCE) | 19-Apr-24 | Sale | 18,253 | $14.02 | $255,907.00 | (< 1%) 3.5M to 3.48M | |
| 18-Apr-24 5:10 PM View: | Neuropace Inc (NPCE) | 18-Apr-24 | Sale | 2,623 | $14.06 | $36,879.40 | (< 1%) 3.5M to 3.5M | |
| 18-Apr-24 5:10 PM View: | Neuropace Inc (NPCE) | 17-Apr-24 | Sale | 300 | $14.15 | $4,245.00 | (< 1%) 3.5M to 3.5M | |
| 18-Apr-24 5:10 PM View: | Neuropace Inc (NPCE) | 16-Apr-24 | Sale | 14,069 | $14.01 | $197,107.00 | (< 1%) 3.52M to 3.5M | |
| 15-Apr-24 5:25 PM View: | Neuropace Inc (NPCE) | 12-Apr-24 | Sale | 23,101 | $14.42 | $333,116.00 | (< 1%) 3.54M to 3.52M | |
| 15-Apr-24 5:25 PM View: | Neuropace Inc (NPCE) | 11-Apr-24 | Sale | 461,899 | $14.49 | $6,692,920.00 | (12%) 4.0M to 3.54M | |
| 05-Apr-24 4:33 PM View: | Kinnate Biopharma Inc. (KNTE) | 03-Apr-24 | Disposition | 8,009,730 | -- | -- | (100%) 8.01M to 0 | |
| 14-Feb-24 4:02 PM View: | Theseus Pharmaceuticals, Inc. (THRX) | 14-Feb-24 | Disposition (change in control) Duplicate | 17,713,600 | -- | -- | (100%) 17.71M to 0 | |
| 31-Jan-24 4:12 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion Duplicate | 2,582,880 | -- | -- | 100% 0 to 2.58M | |
| 31-Jan-24 4:12 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase Duplicate | 444,444 | $18.00 | $7,999,990.00 | 17% 2.58M to 3.03M | |
| 26-Jan-24 7:14 PM View: | Adicet Bio, Inc. (ACET) | 25-Jan-24 | Private Purchase Duplicate | 3,125,000 | $2.40 | $7,500,000.00 | 38% 8.32M to 11.45M | |
| 25-Jan-24 4:28 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Private Purchase | 454,545 | $11.00 | $5,000,000.00 | 3% 14.3M to 14.76M | |
| 16-Jan-24 4:39 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 11-Jan-24 | Exercise (in-the money or at-the-money) Duplicate | 145,251 | $12.74 | $1,850,500.00 | 6% 2.54M to 2.68M | |
| 29-Dec-23 4:18 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 28-Dec-23 | Sale | 1,364,850 | $18.35 | $25,049,000.00 | (35%) 3.9M to 2.54M | |
| 29-Dec-23 4:18 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 27-Dec-23 | Private Sale | 181,498 | $19.96 | $3,622,700.00 | (4%) 4.08M to 3.9M | |
| 20-Dec-23 6:28 PM View: | Disc Medicine, Inc. (IRON) | 18-Dec-23 | Option Exercise | 1,724 | $38.00 | $65,512.00 | < 1% 1.7M to 1.7M | |
| 20-Dec-23 6:28 PM View: | Disc Medicine, Inc. (IRON) | 18-Dec-23 | Option Sale | 1,724 | $59.24 | $102,130.00 | (< 1%) 1.7M to 1.7M | |
| 14-Dec-23 5:44 PM View: | Disc Medicine, Inc. (IRON) | 14-Dec-23 | Sale Duplicate | 200 | $57.73 | $11,546.00 | (< 1%) 2.14M to 2.14M | |
| 15-Dec-23 6:04 PM View: | Disc Medicine, Inc. (IRON) | 14-Dec-23 | Private Sale | 433,200 | $56.75 | $24,584,100.00 | (20%) 2.14M to 1.7M | |
| 14-Dec-23 5:44 PM View: | Disc Medicine, Inc. (IRON) | 13-Dec-23 | Sale Duplicate | 106,700 | $58.56 | $6,248,350.00 | (5%) 2.24M to 2.14M | |
| 14-Dec-23 5:44 PM View: | Disc Medicine, Inc. (IRON) | 12-Dec-23 | Private Sale Duplicate | 27,300 | $60.16 | $1,642,370.00 | (1%) 2.27M to 2.24M | |
| 24-Nov-23 4:38 PM View: | Pmv Pharmaceuticals, Inc. (PMVP) | 22-Nov-23 | Sale | 87,786 | $2.23 | $195,763.00 | (1%) 6.56M to 6.48M | |
| 04-Oct-23 5:36 PM View: | Neuropace Inc (NPCE) | 03-Oct-23 | Sale | 700 | $9.02 | $6,314.00 | (< 1%) 4.0M to 4.0M | |
| 04-Oct-23 5:36 PM View: | Neuropace Inc (NPCE) | 02-Oct-23 | Sale | 7,614 | $9.08 | $69,135.10 | (< 1%) 4.01M to 4.0M |